Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
6.95
0.00 (0.00%)
At close: Sep 4, 2026, 4:00 PM EDT
7.06
+0.11 (1.54%)
Pre-market: Sep 8, 2026, 8:01 AM EDT
Ginkgo Bioworks Holdings Employees
Ginkgo Bioworks Holdings had 485 employees as of December 31, 2025. The number of employees decreased by 349 or -41.85% compared to the previous year.
Employees
485
Change (1Y)
-349
Growth (1Y)
-41.85%
Revenue / Employee
$273,033
Profits / Employee
-$599,594
Market Cap
468.01M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 485 | -349 | -41.85% |
| Dec 31, 2024 | 834 | -384 | -31.53% |
| Dec 31, 2023 | 1,218 | -74 | -5.73% |
| Dec 31, 2022 | 1,292 | 651 | 101.56% |
| Dec 31, 2021 | 641 | 146 | 29.49% |
| Mar 31, 2021 | 495 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Puma Biotechnology | 179 |
| Ocugen | 116 |
| Arcturus Therapeutics Holdings | 111 |
| C4 Therapeutics | 104 |
| Rezolute | 68 |
| Atea Pharmaceuticals | 55 |
| Inhibikase Therapeutics | 35 |
| Relmada Therapeutics | 17 |
DNA News
- 4 weeks ago - Ginkgo Bioworks downgraded to Hold from Buy at TD Cowen - TheFly
- 4 weeks ago - Ginkgo Bioworks Holdings Earnings Call Transcript: Q2 2026 - Transcripts
- 4 weeks ago - Ginkgo Bioworks Holdings Earnings release: Q2 2026 - Filings
- 4 weeks ago - Ginkgo Bioworks Holdings Slides: Q2 2026 - Filings
- 4 weeks ago - Ginkgo Bioworks Holdings Quarterly report: Q2 2026 - Filings
- 3 months ago - Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One™: a High-Throughput ADME Platform That Brings Pharmacokinetic Projection Earlier in Drug Discovery - PRNewsWire
- 4 months ago - Ginkgo Bioworks reaffirms 2026 expected total cash burn of ($150M)-($125M) - TheFly
- 4 months ago - Ginkgo Bioworks Holdings Earnings Call Transcript: Q1 2026 - Transcripts